PLK4 and cancer: Our data suggest a model whereby the combined action of PLK4 inhibition and RT leads to increased overamplification of centrioles, which in turn increases genomic instability, compromises the ability of cancer cells to cope with genotoxic stress and results in enhanced anticancer effects.